Soluble complement receptor type 1 protects rats from lethal shock induced by anti-Crry antibody following lipopolysaccharide priming.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 11893854)

Published in Int Arch Allergy Immunol on January 01, 2002

Authors

Masashi Mizuno1, Kazuhiro Nishikawa, Noriko Okada, Seiichi Matsuo, Hidechika Okada

Author Affiliations

1: Third Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan.

Articles by these authors

Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res (2004) 2.72

Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol (2009) 2.66

Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58

Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis (2010) 2.47

Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol (2008) 2.44

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20

Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant (2011) 2.17

Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol (2002) 1.98

Perforative peritonitis caused by appendicitis in a patient on peritoneal dialysis. Intern Med (2013) 1.97

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95

Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int (2009) 1.72

Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res (2008) 1.70

Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial. Ann Surg Oncol (2013) 1.66

Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. Kidney Int (2008) 1.58

Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. J Am Soc Nephrol (2008) 1.57

Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells Dev (2009) 1.53

A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol (2009) 1.44

Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol (2010) 1.39

Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res (2008) 1.39

GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis (2012) 1.36

ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol (2012) 1.27

Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol Immunol (2002) 1.24

A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. J Clin Invest (2004) 1.24

A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. J Nephrol (2012) 1.24

Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis (2009) 1.23

Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant (2003) 1.19

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol (2008) 1.19

Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol (2013) 1.17

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol (2014) 1.17

Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes (2005) 1.16

Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol (2002) 1.16

Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition. Am J Surg (2006) 1.15

The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma. Clin Cancer Res (2004) 1.13

Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int (2002) 1.09

Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol (2010) 1.09

Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol (2007) 1.09

Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol (2011) 1.08

Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan. Clin Exp Nephrol (2011) 1.08

Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease. Clin Exp Nephrol (2011) 1.07

A murine model of neonatal diabetes mellitus in Glis3-deficient mice. FEBS Lett (2009) 1.07

The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest (2009) 1.06

Kidney regeneration through nephron neogenesis in medaka. Dev Growth Differ (2009) 1.06

Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Lab Invest (2007) 1.05

Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors. AJR Am J Roentgenol (2003) 1.05

Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol (2004) 1.05

Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int (2012) 1.04

Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology (2002) 1.04

Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J (2008) 1.04

Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol (2003) 1.04

Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03

CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. J Physiol (2002) 1.02

eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists. Am J Pathol (2009) 1.01

Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol (2006) 1.00

Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol (2011) 0.99

Prognostic impact of major receptor tyrosine kinase expression in gastric cancer. Ann Surg Oncol (2014) 0.99

Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology (Carlton) (2011) 0.99

Primary leiomyosarcoma of the pancreas--a case report and case review. Virchows Arch (2001) 0.98

Simple sampling strategy for measuring inulin renal clearance. Clin Exp Nephrol (2008) 0.98

Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model. Am J Physiol Renal Physiol (2008) 0.98

Carcinosarcoma of the gallbladder producing alpha-fetoprotein and manifesting as leukocytosis with elevated serum granulocyte colony-stimulating factor: report of a case. Surg Today (2009) 0.97

Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol (2009) 0.97

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin Exp Nephrol (2013) 0.97

Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries. Clin Exp Nephrol (2009) 0.97

Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol (2013) 0.97

Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol (2011) 0.96

Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol (2013) 0.96

Chronic kidney disease in Asia. Lancet (2008) 0.96

Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am J Pathol (2004) 0.96

The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol (2009) 0.95

Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol (2012) 0.95

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors. AIDS (2004) 0.94

Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem (2012) 0.94

Impact of renal function on coronary plaque composition. Nephrol Dial Transplant (2009) 0.94

TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis. J Am Soc Nephrol (2013) 0.93

The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids. Clin Exp Nephrol (2003) 0.93

Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion. Kidney Int (2005) 0.93

Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int (2005) 0.93

Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy. Clin Exp Nephrol (2012) 0.93

A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer. Cancer Res (2002) 0.92

Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals. Mol Ther (2011) 0.92

Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer. Cancer Sci (2010) 0.91

Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats. Cell Transplant (2012) 0.91

Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease. J Immunol (2003) 0.91

Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int (2004) 0.90

Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J Am Soc Nephrol (2013) 0.89

High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin Pract (2008) 0.89

The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study. Trials (2014) 0.89

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol (2014) 0.88

Combined values of serum albumin, C-reactive protein and body mass index at dialysis initiation accurately predicts long-term mortality. Am J Nephrol (2012) 0.88

Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol Immunol (2011) 0.88

A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomized phase II trial (COMPASS-D trial). Jpn J Clin Oncol (2011) 0.88

Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study. Gastric Cancer (2012) 0.87

Downregulation of monocyte chemoattractant protein-1 involving short interfering RNA attenuates hapten-induced contact hypersensitivity. Mol Ther (2007) 0.87